ORCHARD MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C84051 | MANSFIELD, NG18 5GG
Showing results 101-150 of 700
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Insulin glargine | 920 | 3,825 | £35.3K | +224.0% ▲ |
| Betamethasone valerate | 908 | 78.7K | £4.8K | +135.8% ▲ |
| Lercanidipine hydrochloride | 901 | 26.1K | £2.7K | +45.9% ▲ |
| Esomeprazole | 900 | 35.5K | £3.6K | +122.4% ▲ |
| Quetiapine | 848 | 42.8K | £5.5K | +36.2% ▲ |
| Edoxaban | 839 | 24.0K | £39.8K | +19.8% ▲ |
| Carbamazepine | 831 | 75.6K | £5.6K | +180.0% ▲ |
| Pravastatin sodium | 819 | 24.7K | £1.1K | +152.2% ▲ |
| Vitamin B compound | 814 | 64.8K | £2.0K | +484.3% ▲ |
| Oxycodone hydrochloride | 809 | 71.2K | £14.9K | +216.1% ▲ |
| Beclometasone dipropionate | 755 | 766 | £2.2K | +251.0% ▲ |
| Pantoprazole | 749 | 26.2K | £1.2K | +172.5% ▲ |
| 746 | 89.9K | £2.4K | +169.8% ▲ | |
| Warfarin sodium | 745 | 50.4K | £1.6K | +58.0% ▲ |
| Hydroxocobalamin | 740 | 1,065 | £2.2K | +53.8% ▲ |
| Oxybutynin | 728 | 43.0K | £1.8K | +282.2% ▲ |
| Mirabegron | 719 | 20.0K | £18.4K | +79.0% ▲ |
| Dihydrocodeine tartrate | 708 | 64.6K | £5.1K | +262.4% ▲ |
| Perindopril erbumine | 705 | 24.6K | £2.0K | +32.8% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 695 | 59.6K | £2.3K | +126.8% ▲ |
| Loperamide hydrochloride | 694 | 57.6K | £1.9K | +198.0% ▲ |
| Nortriptyline | 694 | 44.5K | £1.8K | +377.0% ▲ |
| Azithromycin | 682 | 11.6K | £2.8K | +438.0% ▲ |
| 675 | 249.8K | £4.6K | +155.9% ▲ | |
| Lactulose | 670 | 386.8K | £3.6K | +103.5% ▲ |
| Ezetimibe | 653 | 19.0K | £3.2K | -8.2% ▼ |
| Sodium valproate | 634 | 140.6K | £12.3K | +99.3% ▲ |
| Clobetasol propionate | 634 | 40.9K | £3.2K | +364.7% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 633 | 642 | £9.0K | +458.1% ▲ |
| Methotrexate | 631 | 17.6K | £1.1K | +93.9% ▲ |
| Biphasic isophane insulin | 630 | 4,749 | £20.0K | +464.7% ▲ |
| Sacubitril/valsartan | 622 | 34.9K | £57.0K | +159.7% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 619 | 57.0K | £3.9K | +173.9% ▲ |
| Loratadine | 611 | 25.4K | £660 | +192.4% ▲ |
| Baclofen | 603 | 101.7K | £2.1K | +201.0% ▲ |
| Mesalazine (Systemic) | 590 | 61.1K | £26.8K | +146.3% ▲ |
| Mometasone furoate | 582 | 31.7K | £3.2K | +335.3% ▲ |
| Clobetasone butyrate | 578 | 30.4K | £2.6K | +183.2% ▲ |
| 559 | 280.9K | £1.9K | +513.1% ▲ | |
| Diltiazem hydrochloride | 557 | 22.9K | £3.8K | +81.4% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 554 | 74.1K | £4.8K | +266.5% ▲ |
| Estradiol | 549 | 12.5K | £6.9K | +103.5% ▲ |
| Sitagliptin | 543 | 15.4K | £1.0K | +39.2% ▲ |
| Digoxin | 540 | 15.5K | £1.1K | +42.7% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 533 | 534 | £23.7K | +218.7% ▲ |
| Methylprednisolone acetate | 531 | 539 | £1.7K | +359.9% ▲ |
| Glyceryl trinitrate | 525 | 629 | £1.3K | +122.0% ▲ |
| Progesterone | 521 | 79.5K | £14.1K | +24.5% ▲ |
| Estradiol with progestogen | 520 | 32.6K | £32.1K | +52.6% ▲ |
| Prochlorperazine maleate | 519 | 38.2K | £2.2K | +156.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.